Are complex therapies required as pharmacological treatments of fibromyalgia?

LAWSON, Kim (2007). Are complex therapies required as pharmacological treatments of fibromyalgia? Future Rheumatology, 2 (6), 599-605.

Full text not available from this repository.
Official URL: http://dx.doi.org/10.2217/17460816.2.6.599
Link to published version:: https://doi.org/10.2217/17460816.2.6.599
Related URLs:

    Abstract

    Fibromyalgia (FM), a chronic pain condition with many auxiliary symptoms and co-morbidities, is estimated to affect 2–4% of the general population. Current management involves medications that remain largely empiric, which many patients may find either insufficient to control their symptoms or difficult to tolerate. The lack of a complete understanding of the pathophysiological processes underlying this condition limits the ability to provide rationally designed, mechanistically based treatments. As a consequence, treatment is often directed towards individual symptoms rather than management of the condition. This has resulted in limited success of clinical trials in FM, which may be related to an apparent reductionist approach to their design for the evaluation of a complex condition. The complexity of FM suggests that, to date, monotherapy will not adequately address the condition.

    Item Type: Article
    Research Institute, Centre or Group - Does NOT include content added after October 2018: Biomolecular Sciences Research Centre
    Identification Number: https://doi.org/10.2217/17460816.2.6.599
    Page Range: 599-605
    Depositing User: Jamie Young
    Date Deposited: 28 May 2015 11:19
    Last Modified: 13 Jun 2017 13:29
    URI: http://shura.shu.ac.uk/id/eprint/9916

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics